Trials / Completed
CompletedNCT01096173
Determination of the in Vitro Effects of Cationic Airway Lining Modulators (CALM) on Chronic Obstructive Pulmonary Disease (COPD) Sputum
Determination of the in Vitro Effects of CALM on COPD Sputum
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (estimated)
- Sponsor
- Pulmatrix Inc. · Industry
- Sex
- All
- Age
- 35 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This study is intended to be an evaluation of the properties of human sputum collected from patients with COPD. It is hypothesized that cationic airway lining modulators will have beneficial effects on the rheological properties of sputum derived from patients with COPD. Approximately 10 patients with COPD will collect sputum at home for 5 days. Samples will be collected and tested in laboratory tests.
Conditions
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2010-06-01
- Completion
- 2010-10-01
- First posted
- 2010-03-30
- Last updated
- 2011-04-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01096173. Inclusion in this directory is not an endorsement.